Comparison of effectiveness of biosimilar filgrastim (Nivestimâ„¢), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study
Crossref DOI link: https://doi.org/10.1007/s00520-015-2818-2
Published Online: 2015-06-27
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brito, M. http://orcid.org/0000-0002-6104-5902
Esteves, S.
André, R.
Isidoro, M.
Moreira, A.
Text and Data Mining valid from 2015-06-27